11.09 am | 24 Dec 2012 |  Source: CNBC-TV18

Buy Strides Arcolab, says Sudarshan Sukhani of s2analytics.com. It has been moving up in a steady up move. At this point there was a small correction ...

11.45 am | 22 Dec 2012 |  Source: CNBC-TV18

In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his views on stocks across various sectors. He picked four multibagger stocks for the...

2.45 pm | 05 Dec 2012 |  Source: Moneycontrol.com

Bangalore-based Strides Arcolab and global pharma major Eli Lilly and Co have entered into a strategic partnership to expand delivery of cancer medici...

9.48 am | 04 Dec 2012 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Aashish Tater, Head of Research at Fortunewizard.com recommends Punjab and Sind Bank and Aurobindo Pharma as multibagger...

4.30 pm | 29 Nov 2012 |  Source: PTI

Strides Arcolab today said its wholly-owned arm Onco Therapies has received approval from US health regulator for its generic version of cancer drug I...

12.32 pm | 29 Nov 2012 |  Source: Moneycontrol.com

Strides Arcolab receives US FDA approval for Ifosfamide injection...

12.48 pm | 23 Nov 2012 |  Source: CNBC-TV18

In CNBC-TV18's popular show Bull's Eye, SP Tulsian of sptulsian.com shares trading strategy of the day....

8.45 am | 23 Nov 2012 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

6.45 pm | 19 Nov 2012 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com adviced traders to buy Strides Arcolab and SREI Infra on dip....

12.58 pm | 23 Oct 2012 |  Source: Moneycontrol.com

Dolat Capital is bullish on Strides Arcolab and has recommended buy rating on the stock with a target of Rs 935 in its October 22, 2012 research repor...

2.45 pm | 22 Oct 2012 |  Source: Moneycontrol.com

ICICIdirect.com is bullish on Strides Arcolab and has recommended buy rating on the stock with a target of Rs 1007 in its October 22, 2012 research re...

12.35 pm | 20 Oct 2012 |  Source: Moneycontrol.com

Strides Arcolab has reported a sales turnover of Rs 187.74 crore and a net profit of Rs 30.11 crore for the quarter ended Sep '12...

11.41 am | 19 Oct 2012 |  Source: Moneycontrol.com

Strides Arcolab receives 2 more approvals for Oncology products from USFDA...

9.28 am | 19 Oct 2012 |  Source: Moneycontrol.com

Strides Arcolab has received US FDA approval for Idarubicin Injection, reports CNBC-TV18. At 09:27 hrs Strides Arcolab was quoting at Rs 906, up Rs 9....

5.41 pm | 13 Sep 2012 |  Source: PTI

Pharmaceutical firm Strides Arcolab today said its injectables unit Agila Specialties has received US Food and Drug Administration (USFDA) approval fo...

1.40 pm | 10 Sep 2012 |  Source: Moneycontrol.com

Strides Arcolab allots 27,250 equity shares under ESOP Scheme...

2.17 pm | 03 Sep 2012 |  Source: Moneycontrol.com

Strides Arcolab receives US FDA approval for Vinorelbine Injection...

2.41 pm | 29 Aug 2012 |  Source: PTI

Drug firm Strides Arcolab today said its subsidiary has received US health regulator's approval to market generic topotecan hydrochloride injection, a...

11.48 am | 29 Aug 2012 |  Source: Moneycontrol.com

Strides Arcolab receives US FDA approval for Topotecan Injection...

2.04 pm | 08 Aug 2012 |  Source: PTI

Pharma firm Strides Arcolab today said its subsidiary Onco Therapies Ltd has received final approval from the US health regulator for its generic vers...